Not only are they crushing EPS. Extremely good chart position falling wedge could break out for a big gain. Definitely watching closely and volume alerts.
Couple shots on goal here in the near term, mainly accelerating revenue based off existing sales of PCR based COVID tests plus a new 12-min rapid antigen test coming in Feb. This is a turnaround play as the stock was previously priced for bankruptcy. Valuation should be 10-12x sales or $25-$30. Patience on this one, its a slow grinder.
It looks like the 50MA is acting as support and the price is very close to the POC which is also at the .23 fibonacci level The MACD is crossing. First target $4.68
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.
COVID-19 plays are very hot ATM. One of the most consistent themes that have the most runners. Trinity Biotech has reported that they have been awaiting approval for EUA from the FDA for their COVID-19 tests called "ELISA" . $trib claims their tests are a lot faster. They've ran up to double digits during past pandemics so this play could very well likely also be...
Hello,
My Thoughts For You
This chart is showing the weekly timeframe and we can see that there has been a rejection and if we look at the daily TF there has been a rejection 3 times and 4 times on the 4hr TF. I expect a move down is emanant after being rejected on so many time frames.
If you're not sure how to get into a trade or when to take profits then...
reasons for the downmove:
US Food and Drug Administration (FDA)
had raised concerns over the Troponin device’s temperature range
close facility in Sweden and move it to Ireland, which
will reduce its cost base to US$1.5mln from US$9mln
accounts will include a US$50mln write-off.
cutting 40 jobs.
Trinity will engage with the FDA for the approval
being...
On the daily chart notice that again two of the three indicators are pointing up. the stock is has formed a rising triangle that is about to smash into down trend line. A serious breakout could have impacts on the higher time frame charts. This is a stock to add to your watch list.
weekly
Same story has the monthly. two of three indicators pointing up and there...
